Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment &lt;br&gt;A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&amp;nbsp;Trial

Elisa Perger; Luigi Taranto‐Montemurro; Débora Rosa; Stefano Vicini; Mariapaola Marconi; Lucia Zanotti; P. Meriggi; Ali Azarbarzin; Scott A. Sands; Andrew Wellman; Carolina Lombardi; Gianfranco Parati

doi:10.2139/ssrn.3774180

Related publications

Article2021

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Elisa Perger, Luigi Taranto‐Montemurro, Daniela Santoro Rosa, Stefano Vicini, Manuel Marconi, L Zanotti, P. Meriggi, Ali Azarbarzin, Scott A. Sands, Andrew Wellman, Carolina Lombardi, Gianfranco Parati

Article2021

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Elisa Perger, Paolo Castiglioni, Débora Rosa, Stefano Vicini, P. Meriggi, Andrea Faini, Laura Pini, Luigi Taranto‐Montemurro, Carolina Lombardi, Gianfranco Parati

Article2023

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

Elisa Perger, Paolo Castiglioni, Andrea Faini, Davide Soranna, Antonella Zambon, Débora Rosa, Stefano Vicini, P. Meriggi, Laura Pini, Claudia Baratto, Sergio Caravita, Ali Azarbarzin, Gianfranco Parati, Carolina Lombardi

Article2010

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Jean Louis Vincent, Derek C. Angus, Naoki Aikawa, Ignace Demeyer, Stephen M. Sainati, Nicholas Amlot, Charlie Cao, Masayuki Ii, Hideyasu Matsuda, Kouji Mouri, Jon Cohen

Article2012

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial

Peter Pickkers, Suzanne Heemskerk, Jeroen Schouten, Pierre-François Laterre, Jean Louis Vincent, Albertus Beishuizen, Philippe G. Jorens, Herbert Spapen, Michael Bulitta, Wilbert H.M. Peters, Johannes G. van der Hoeven

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment <br>A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&nbsp;Trial

Discussion(0)

Related publications

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment &lt;br&gt;A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover&amp;nbsp;Trial

Discussion(0)

Related publications

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment

Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial

Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment <br>A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover Trial